Le Lézard
Classified in: Health
Subject: FDA

Sonavex Receives FDA 510(k) Clearance for EchoSure


BALTIMORE, March 11, 2019 /PRNewswire-PRWeb/ -- Sonavex, Inc., a privately held medical device company focused on empowered patient care, announced today that on March 8, 2019 it received 510(k) clearance from the U.S. Food and Drug Administration for its EchoSure device to deliver definitive blood flow data on demand.

The EchoSure system combines 3D ultrasound imaging with advanced deep learning algorithms to automate visual and quantitative blood flow monitoring after surgery. Coupled with Sonavex's FDA-cleared EchoMark® bioresorbable markers, EchoSure eliminates the need for ultrasound expertise in order to measure blood flow. The EchoSure App enables surgeons to monitor patients remotely from their mobile devices.

"For decades, the surgical community has sought a simple, fast and non-invasive way to accurately quantify blood flow after microvascular and vascular surgeries," said Devin O'Brien Coon, MD, Chief Medical Officer and President of Sonavex and a board-certified plastic and microvascular surgeon at Johns Hopkins. "Putting ultrasound technology in the hands of bedside nurses for the first time may enable detection of vascular compromise earlier than clinical observation alone, providing opportunities for more rapid intervention and improved patient outcomes."

This news follows within months of FDA clearance of Sonavex's EchoMark device. "The Sonavex team worked tirelessly for more than five years to create a solution that enables surgeons and nurses to easily collect vital information in real-time so they can provide the best results for their patients," said David Narrow, CEO of Sonavex. "This is a critical milestone in our mission to bring transformative ultrasound technologies to patients, and we are excited to ramp up commercialization efforts this spring."

EchoMark and EchoSure are both available from Sonavex for clinical use across the United States.

---

About Sonavex, Inc.
Sonavex, Inc. is a Baltimore-based medical device company originally spun out of Johns Hopkins. The company has developed a portfolio of novel ultrasound solutions that empower patient care by delivering critical visual and quantitative data to improve outcomes and reduce costs. For more information, please visit http://www.sonavex.com.

 

SOURCE Sonavex


These press releases may also interest you

at 19:18
The U.S. Food and Drug Administration (FDA) today continued to take action in the ongoing response to the COVID-19 pandemic: As part of the FDA's effort to protect consumers, the agency issued a warning letter to one company for selling fraudulent...

at 19:10
With Arizona positive polymerise chain reaction (PCR) COVID-19 cases surging from 63,831 to 85,445?in one week, HeroZona Foundation, in conjunction with SRP, Cox, Travis L. Williams American Legion Post 65, Maricopa County's District 5, the Arizona...

at 19:06
Ringmaster Technologies - a cloud-based healthcare software provider focused on simplifying and enhancing Stop-Loss administrative processes - is pleased to announce a strategic partnership with PLEXIS Healthcare Systems, a global industry leader in...

at 18:20
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Chicago, Illinois for 2020. The informational guide recognizes the top 10 rehab facilities based on cost,...

at 18:15
Heart & Stroke welcomes the final set of regulations announced today by Health Minister Patty Hajdu to further restrict e-cigarette marketing and promotion.   "We are pleased to see Health Canada taking much needed action to protect young people from...

at 18:00
Help.org, a trusted online resource for individuals who struggle with addiction and their loved ones, has announced the Best Rehab Facilities in Cincinnati, Ohio for 2020. The informational guide recognizes the top 10 rehab facilities based on cost,...



News published on 11 march 2019 at 09:30 and distributed by: